Duke Cancer Institute

Home
United States
Durham, NC
Duke Cancer Institute

We have created a collaborative powerhouse as adaptive and multiform as cancer itself––audacious, evolving and unconventional. Is the risk higher? Yes.
(569)

We have created a collaborative powerhouse as adaptive and multiform as cancer itself––audacious, evolving, unconventional––at the center of a world-renowned university and medical center. This is how we’re changing the rules on cancer. Critical Mass of Talent
At Duke we know something about building great teams. Rising stars and renowned leaders alike come here to join DCI’s global front-runners in science, medicine and technology. We recruit and encourage these tenacious investigators and physicians with an ethos of original thinking and collaboration to accelerate and expand their pioneering work. Game-Changing Research
We take the road less traveled to find breakthrough discoveries. Inspired by the bravery of our patients, we have become unafraid to pursue even outrageous possibilities. And sometimes we fall short. But when we succeed, we give the world the kind of breakthroughs that don’t always occur in other laboratories. Synchronous Collaborations
We are moving further, faster and with greater purpose. We draw from Duke’s entire pool of world-class talent and resources to create non-linear exchanges of knowledge and innovation. By doing so, we exponentially increase the probability of advances to transform cancer prevention, treatments and survivorship. Integrated Patient Care
A ground-breaking model for patient care is being fostered here. We organized our flagship cancer center to assemble each patient’s entire clinical team and treatment resources in a single state-of-the-art facility. With a total integration of clinical research, treatment and support services to deliver cancer care as it should be. Support our Work! http://bit.ly/1OmtPna

To learn more about cancer care at Duke, visit https://www.dukemedicine.org/treatments/cancer.

01/29/2026

Researchers found an antibody that seems to play a role in people with better lung cancer prognoses. DCI's Barton Haynes spoke to The New York Times about how these findings could be turned into a drug.

https://duke.is/c/v9nd

Duke Health | Duke University School of Medicine

Researchers found an antibody that seems to play a role in people with better lung cancer prognoses, but turning it into a treatment could be difficult.

01/27/2026

The CRUSH Colorectal Cancer 5K raises community awareness and funds for colorectal cancer research at the Duke Cancer Institute. Registration is now open for this year's event.

📆 Saturday, March 14 | 10 a.m.-noon

https://duke.is/n/9kdv

01/23/2026

DCI's Megan Huchko, MD, spoke with CBS 17 about prevention and regular screening for for as part of Cervical Cancer Awareness Month.

https://duke.is/r/yw3h

Duke Health

DURHAM, N.C. (WNCN) — January is Cervical Cancer Awareness Month. It aims to educate women about prevention and encourage regular screening. According to 2025 data from the North Carolina Departmen…

01/22/2026

DCI's Trudy Oliver, PhD, spoke with the American Association of Colleges and Universities podcast about her research on small cell .

https://duke.is/9/7mwz

Duke University School of Medicine | Duke Health

A VOICE AND A FORCE FOR LIBERAL EDUCATION. AAC&U advances the vitality and democratic purposes of undergraduate liberal education.

01/21/2026

Join us for the 7th annual She Dunks on Endometrial Cancer Educational Symposium. The event will present multiple award-winning abstracts and research posters focused on advancing research in endometrial cancer.

📆 Sunday, Feb. 8 | 9 a.m.-noon

https://duke.is/8/93en

Duke Health

She Dunks on Endometrial Cancer at Duke Cancer Institute.

01/20/2026

https://duke.is/r/r5wq

A chemotherapy infusion pump may be a treatment option for people whose metastatic colorectal cancer has spread to the liver. Duke Health surgical oncologists were the first to implant the hepatic artery infusion pump; now, they're leading the field through an international collaborative and by chairing national clinical trials.

Duke Health

A chemotherapy infusion pump is giving more time to people with metastatic colorectal cancer that spread to the liver who may have been told they are out of options. Duke Health specialists are trained to offer hepatic arterial infusion (HAI).

01/16/2026

Joel Graybeal knows what it means to be part of a community that cares. After his diagnosis of metastatic prostate cancer, Joel and his family found hope and healing through the collaborative, compassionate care at Duke Cancer Institute.

To show their gratitude, the Graybeals are raising $250,000 to support prostate and urologic cancer research and care, helping others receive the same extraordinary support they experienced.

Stories like Joel’s remind us why generosity matters. On February 12, during our annual Thank-a-thon, we’ll be calling donors to say thank you for making moments like this possible.

🔗 Want to see more stories of generosity in action? Discover how donors like you make a difference every day: https://heyzine.com/flip-book/d80ae7ea2c.html /1

01/15/2026

“Adding or subtracting a medication from a patient’s list could mean the difference between cure or not.”

A Duke Health team led by Dr. Nicholas DeVito with the Duke Cancer Institute found that common over-the-counter medications like acetaminophen or heartburn drugs may influence how well cancer immunotherapy works.

Read the full story: https://duke.is/g/z8ka

| | Duke University School of Medicine

01/13/2026

DCI has launched the Pancreatic Cancer Center, a multidisciplinary hub that seeks to improve outcomes for patients with or at risk for pancreatic cancer through prevention, early detection, and treatment.

https://duke.is/4/e2j5

| Duke Health | Duke University School of Medicine

01/07/2026

Triple-negative represents a heterogeneous group of tumors that, until now, have largely been treated the same way. Researchers at DCI are working to change that.

https://duke.is/v/9a4e

Duke Health | Duke University School of Medicine

Triple-negative breast cancer represents a heterogeneous group of tumors that, until now, have largely been treated the same way. Researchers at DCI are working to change that.

01/02/2026

Decades of investment in HIV science has reshaped medicine beyond the virus itself, including powering modern cancer immunotherapies and accelerating gene & vaccine technologies for cancer treatments.

https://duke.is/9/mzcc

Duke University School of Medicine

A new Nature Medicine paper highlights how 40 years of HIV research reshaped far more than the fight against one virus. What began as an urgent global health response helped fuel breakthroughs that now power treatments for cancer, tuberculosis, hepatitis, and even COVID-19 — thanks to sustained U....

12/29/2025

The DCI Supportive Care and Survivorship Center provides cancer support and survivorship services to patients and their families.

Learn more about the services available through the center:

The Center provides cancer support and survivorship services to patients and their families. Our goal is to wrap these individuals in a community of support while providing high-quality services that improve health outcomes.

Address

20 Duke Medicine Circle
Durham, NC
27710

Website

https://www.dukehealth.org/treatments/cancer

Alerts

Be the first to know and let us send you an email when Duke Cancer Institute posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Duke Cancer Institute:

Shortcuts

Want your practice to be the top-listed Clinic in Durham?